Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 541695, 17 pages
http://dx.doi.org/10.1155/2013/541695
Research Article

Curcumin Suppresses Metastasis via Sp-1, FAK Inhibition, and E-Cadherin Upregulation in Colorectal Cancer

1Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei 100, Taiwan
2Center of Genomic Medicine, National Taiwan University, Taipei 100, Taiwan
3Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei 100, Taiwan
4Department of Laboratory Medicine, National Taiwan University Hospital, Taipei 100, Taiwan
5Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei 100, Taiwan
6Center for Optoelectronic Biomedicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan

Received 12 April 2013; Accepted 17 June 2013

Academic Editor: Hyung-In Moon

Copyright © 2013 Chun-Chieh Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2012,” CA Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. C.-J. Chiang, Y.-C. Chen, C.-J. Chen, S.-L. You, and M.-S. Lai, “Cancer trends in Taiwan,” Japanese Journal of Clinical Oncology, vol. 40, no. 10, pp. 897–904, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Pourhoseingholi, “Increased burden of colorectal cancer in Asia,” The World Journal of Gastrointestinal Oncology, vol. 4, pp. 68–70, 2012. View at Publisher · View at Google Scholar
  4. M. F. Leber and T. Efferth, “Molecular principles of cancer invasion and metastasis,” International Journal of Oncology, vol. 34, no. 4, pp. 881–895, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. Q. Shi, X. Le, J. L. Abbruzzese et al., “Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma,” Cancer Research, vol. 61, no. 10, pp. 4143–4154, 2001. View at Google Scholar · View at Scopus
  6. A. Zannetti, S. Del Vecchio, M. V. Carriero et al., “Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma,” Cancer Research, vol. 60, no. 6, pp. 1546–1551, 2000. View at Google Scholar · View at Scopus
  7. Y. Kitadai, W. Yasui, H. Yokozaki et al., “The level of a transcription factor Sp1 is correlated with the expression of EGF receptor in human gastric carcinomas,” Biochemical and Biophysical Research Communications, vol. 189, no. 3, pp. 1342–1348, 1992. View at Publisher · View at Google Scholar · View at Scopus
  8. D. D. Schlaepfer, C. R. Hauck, and D. J. Sieg, “Signaling through focal adhesion kinase,” Progress in Biophysics and Molecular Biology, vol. 71, no. 3-4, pp. 435–478, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. T.-L. Shen and J.-L. Guan, “Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts,” The FEBS Letters, vol. 499, no. 1-2, pp. 176–181, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. Q. Yu and I. Stamenkovic, “Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis,” Genes and Development, vol. 14, no. 2, pp. 163–176, 2000. View at Google Scholar · View at Scopus
  11. F. van Roy and G. Berx, “The cell-cell adhesion molecule E-cadherin,” Cellular and Molecular Life Sciences, vol. 65, no. 23, pp. 3756–3788, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. R. Davie, S. He, L. Li et al., “Nuclear organization and chromatin dynamics—Sp1, Sp3 and histone deacetylases,” Advances in Enzyme Regulation, vol. 48, no. 1, pp. 189–208, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. H.-M. Chen, H. L. Pahl, R. J. Scheibe, D.-E. Zhang, and D. G. Tenen, “The Sp1 transcription factor binds the CD11b promoter specifically in myeloid cells in vivo and is essential for myeloid-specific promoter activity,” Journal of Biological Chemistry, vol. 268, no. 11, pp. 8230–8239, 1993. View at Google Scholar · View at Scopus
  14. X. Wang, A. M. Urvalek, J. Liu, and J. Zhao, “Activation of KLF8 transcription by focal adhesion kinase in human ovarian epithelial and cancer cells,” Journal of Biological Chemistry, vol. 283, no. 20, pp. 13934–13942, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. S. Waby, H. Chirakkal, C. Yu et al., “Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line,” Molecular Cancer, vol. 9, article 275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. B. D. Cox, M. Natarajan, M. R. Stettner, and C. L. Gladson, “New concepts regarding focal adhesion kinase promotion of cell migration and proliferation,” Journal of Cellular Biochemistry, vol. 99, no. 1, pp. 36–52, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Baumann, W. Thiele, N. Cremers et al., “CD24 interacts with and promotes the activity of c-src within lipid rafts in breast cancer cells, thereby increasing integrin-dependent adhesion,” Cellular and Molecular Life Sciences, vol. 69, no. 3, pp. 435–448, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Christofori, “New signals from the invasive front,” Nature, vol. 441, no. 7092, pp. 444–450, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. N. P. Bretz, A. V. Salnikov, C. Perne et al., “CD24 controls Src/STAT3 activity in human tumors,” Cellular and Molecular Life Sciences, vol. 69, pp. 3863–3879, 2012. View at Google Scholar
  20. P. Ye, M. A. Nadkarni, and N. Hunter, “Regulation of E-cadherin and TGF-β3 expression by CD24 in cultured oral epithelial cells,” Biochemical and Biophysical Research Communications, vol. 349, no. 1, pp. 229–235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Chen, Y. Wang, H. Xia et al., “Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis,” Molecular Biology Reports, vol. 39, pp. 6707–6714, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Orsulic, O. Huber, H. Aberle, S. Arnold, and R. Kemler, “E-cadherin binding prevents β-catenin nuclear localization and β-catenin/LEF-1-mediated transactivation,” Journal of Cell Science, vol. 112, no. 8, pp. 1237–1245, 1999. View at Google Scholar · View at Scopus
  23. S. C. Gupta, S. Prasad, J. H. Kim et al., “Multitargeting by curcumin as revealed by molecular interaction studies,” Natural Product Reports, vol. 28, no. 12, pp. 1937–1955, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Kuttan, P. Bhanumathy, K. Nirmala, and M. C. George, “Potential anticancer activity of turmeric (Curcuma longa),” Cancer Letters, vol. 29, no. 2, pp. 197–202, 1985. View at Google Scholar · View at Scopus
  25. A. J. Ruby, G. Kuttan, K. Dinesh Babu, K. N. Rajasekharan, and R. Kuttan, “Anti-tumour and antioxidant activity of natural curcuminoids,” Cancer Letters, vol. 94, no. 1, pp. 79–83, 1995. View at Google Scholar · View at Scopus
  26. H. Chen, Z.-S. Zhang, Y.-L. Zhang, and D.-Y. Zhou, “Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells,” Anticancer Research, vol. 19, no. 5, pp. 3675–3680, 1999. View at Google Scholar · View at Scopus
  27. H.-W. Chen, J.-Y. Lee, J.-Y. Huang et al., “Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1,” Cancer Research, vol. 68, no. 18, pp. 7428–7438, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. J.-Y. Lee, Y.-M. Lee, G.-C. Chang et al., “Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy,” PLoS ONE, vol. 6, no. 8, Article ID e23756, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. H.-J. Lin, C.-C. Su, H.-F. Lu et al., “Curcumin blocks migration and invasion of mouse-rat hybrid retina ganglion cells (N18) through the inhibition of MMP-2, -9, FAK, Rho a and Rock-1 gene expression,” Oncology Reports, vol. 23, no. 3, pp. 665–670, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Shishodia, T. Singh, and M. M. Chaturvedi, “Modulation of transcription factors by curcumin,” Advances in Experimental Medicine and Biology, vol. 595, pp. 127–148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. J. H. Leupold, H.-S. Yang, N. H. Colburn, I. Asangani, S. Post, and H. Allgayer, “Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors,” Oncogene, vol. 26, no. 31, pp. 4550–4562, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S.-G. Cho, Z. Yi, X. Pang et al., “Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation,” Cancer Research, vol. 69, no. 17, pp. 7062–7070, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Chadalapaka, I. Jutooru, S. Chintharlapalli et al., “Curcumin decreases specificity protein expression in bladder cancer cells,” Cancer Research, vol. 68, no. 13, pp. 5345–5354, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Aigner, C. L. Ramos, A. Hafezi-Moghadam et al., “CD24 mediates rolling of breast carcinoma cellson P-selectin,” The FASEB Journal, vol. 12, no. 12, pp. 1241–1251, 1998. View at Google Scholar · View at Scopus
  35. Z. Lou, S. O'Reilly, H. Liang, V. M. Maher, S. D. Sleight, and J. J. McCormick, “Down-regulation of overexpression Sp1 protein in human fibrosarcoma cell lines inhibits tumor formation,” Cancer Research, vol. 65, no. 3, pp. 1007–1017, 2005. View at Google Scholar · View at Scopus
  36. D. Yamamoto, Y. Sonoda, M. Hasegawa, M. Funakoshi-Tago, E. Aizu-Yokota, and T. Kasahara, “FAK overexpression upregulates cyclin D3 and enhances cell proliferation via the PKC and PI3-kinase-Akt pathways,” Cellular Signalling, vol. 15, no. 6, pp. 575–583, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. G. W. McLean, N. H. Komiyama, B. Serrels et al., “Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression,” Genes and Development, vol. 18, no. 24, pp. 2998–3003, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. J. W. Lee, Y. H. Kim, H. B. Park et al., “The C-terminal domain of focal adhesion kinase reduces the tumor cell invasiveness in chondrosarcoma cell lines,” Journal of Orthopaedic Research, vol. 21, no. 6, pp. 1071–1080, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. M. B. Calalb, T. R. Polte, and S. K. Hanks, “Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases,” Molecular and Cellular Biology, vol. 15, no. 2, pp. 954–963, 1995. View at Google Scholar · View at Scopus
  40. D. D. Schlaepfer and T. Hunter, “Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases,” Molecular and Cellular Biology, vol. 16, pp. 5623–5633, 1996. View at Google Scholar
  41. T.-H. Leu, S. L. Su, Y.-C. Chuang, and M.-C. Maa, “Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity,” Biochemical Pharmacology, vol. 66, no. 12, pp. 2323–2331, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Kim, S.-J. Kim, S.-S. Kang, and E.-J. Jin, “Curcumin inhibits cellular condensation and alters microfilament organization during chondrogenic differentiation of limb bud mesenchymal cells,” Experimental and Molecular Medicine, vol. 41, no. 9, pp. 656–664, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Ilic, Y. Furuta, T. Suda et al., “Focal adhesion kinase is not essential for in vitro and in vivo differentiation of ES cells,” Biochemical and Biophysical Research Communications, vol. 209, no. 1, pp. 300–309, 1995. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Tamura, J. Gu, T. Takino, and K. M. Yamada, “Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130(Cas),” Cancer Research, vol. 59, no. 2, pp. 442–449, 1999. View at Google Scholar · View at Scopus
  45. P. K. Sood, U. Nahar, and B. Nehru, “Curcumin attenuates aluminum-induced oxidative stress and mitochondrial dysfunction in rat brain,” Neurotoxicity Research, vol. 20, no. 4, pp. 351–361, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Wang, R. Liu, D. Li et al., “A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis,” American Journal of Translational Research, vol. 4, pp. 347–356, 2012. View at Google Scholar
  47. V. A. Torres, J. C. Tapia, D. A. Rodriguez et al., “E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced β-catenin-Tcf/Lef- dependent transcription,” Molecular and Cellular Biology, vol. 27, no. 21, pp. 7703–7717, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. V. Sundram, S. C. Chauhan, M. Ebeling, and M. Jaggi, “Curcumin attenuates β-catenin signaling in prostate cancer cells through activation of protein kinase D1,” PLoS ONE, vol. 7, no. 4, Article ID e35368, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. T.-S. Wong, W.-S. Chan, C.-H. Li et al., “Curcumin alters the migratory phenotype of nasopharyngeal carcinoma cells through up-regulation of E-cadherin,” Anticancer Research, vol. 30, no. 7, pp. 2851–2856, 2010. View at Google Scholar · View at Scopus
  50. J. M. Lee, S. Dedhar, R. Kalluri, and E. W. Thompson, “The epithelial-mesenchymal transition: new insights in signaling, development, and disease,” Journal of Cell Biology, vol. 172, no. 7, pp. 973–981, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Huang, Z. Chen, and L. Fang, “Curcumin inhibits LPS-induced EMT through downregulation of NF-kappaB-Snail signaling in breast cancer cells,” Oncology Reports, vol. 29, pp. 117–124, 2013. View at Google Scholar
  52. K. Jungert, A. Buck, G. von Wichert et al., “Sp1 is required for transforming growth factor-β-induced mesenchymal transition and migration in pancreatic cancer cells,” Cancer Research, vol. 67, no. 4, pp. 1563–1570, 2007. View at Publisher · View at Google Scholar · View at Scopus